Support federal scheduling of concentrated synthetic 7-hydroxymitragynine (7-OH) as a Schedule I controlled substance.

Gus M. Bilirakis · Florida · Republican

policy impact 0.68 specificity 0.89 extraction confidence 92%

Contest this claim

Occurrences

Evidence

The article says federal anti-7-OH directives have intensified the dispute and quotes the administration as working to "address the dangers posed by synthetic and highly concentrated 7-hydroxymitragynine ('7OH') products," while the industry waits to see whether federal prohibition will follow.

No Bilirakis-specific federal action surfaced in the lookback window; the broader federal 7-OH scheduling push was still active and not yet resolved.

unresolved same_term

The Kratom Civil War Is Heating Up, and MAHA Has Picked a Side
secondary · model gpt-5.4-mini · confidence 41%

Contest this evidence item

Assessments

unresolved unknown

The available evidence indicates that a broader federal push to address synthetic and highly concentrated 7-hydroxymitragynine products was still active as of June 15, 2026, but it does not show that concentrated synthetic 7-OH had been formally scheduled as a Schedule I controlled substance. It also does not identify Bilirakis as having written, sponsored, or materially advanced a completed federal scheduling action. Because the promised outcome remained pending and Bilirakis-specific delivery evidence is absent, the promise is best scored as unresolved rather than delivered, partial, or never.

provider codex_cli · model gpt-5.4 · confidence 70%